Clinical trial
Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and…
NCT00490178 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00490178 |
|---|---|
| Title | Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia |
| Official title | An Open Label, Multicenter Trial Assessing the Acceptability of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Patients With Type 2 Diabetes and Dyslipidemia |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Dyslipidemia |
| Intervention type | Drug |
| Interventions | Fenofibrate 80 mg and metformin 1000 mg (fixed combination) |
| Enrollment | 29 |
| Start date | Mar 1, 2007 |
| First posted | Jun 22, 2007 |
| Last update posted | Sep 3, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: